Subtopic Deep Dive
Pharmacokinetics of Intravenous Ascorbic Acid
Research Guide
What is Pharmacokinetics of Intravenous Ascorbic Acid?
Pharmacokinetics of intravenous ascorbic acid studies the absorption, distribution, metabolism, and excretion of high-dose vitamin C administered intravenously, focusing on plasma concentration profiles, bioavailability, and dose-dependent behaviors in humans.
Research compares IV versus oral routes, revealing near-complete bioavailability and peak plasma levels exceeding 1 mM with IV doses (Doseděl et al., 2021, 474 citations). Phase I trials established safety in sepsis patients at 6 g every 6 hours (Fowler et al., 2014, 560 citations). Over 20 papers detail tissue distribution and clearance models.
Why It Matters
Precise pharmacokinetic data guide IV vitamin C dosing in sepsis and septic shock, as shown in safety trials (Fowler et al., 2014) and combination therapies (Fujii et al., 2020). This informs critical care protocols, optimizing antioxidant effects while minimizing risks during chemotherapy (Lawenda et al., 2008). Accurate modeling prevents under- or overdosing in therapeutic applications like COVID-19 treatment (Wu et al., 2020).
Key Research Challenges
Dose-Dependent Nonlinear Kinetics
High IV doses saturate renal reabsorption, causing nonlinear clearance that complicates dosing models (Doseděl et al., 2021). Standard pharmacokinetic equations fail above 3 g/m². Trials like Fowler et al. (2014) highlight variable patient responses in sepsis.
IV vs Oral Bioavailability Gap
Oral ascorbic acid achieves only micromolar plasma levels due to tight junction regulation, unlike IV millimolar peaks (Mandl et al., 2009). This limits oral efficacy for acute therapy. Studies quantify the gap but lack unified transport models.
Tissue Distribution Modeling
Ascorbate accumulates in leukocytes and tumors, but multi-compartment models remain underdeveloped (Carr and Maggini, 2017). Sepsis alters distribution (Fowler et al., 2014). Needs better imaging and sampling methods.
Essential Papers
Vitamin C and Immune Function
Anitra C. Carr, Silvia Maggini · 2017 · Nutrients · 1.9K citations
Vitamin C is an essential micronutrient for humans, with pleiotropic functions related to its ability to donate electrons. It is a potent antioxidant and a cofactor for a family of biosynthetic and...
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
Klaudia Jomová, Renáta Raptová, Suliman Yousef Alomar et al. · 2023 · Archives of Toxicology · 1.9K citations
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo et al. · 2020 · Current Pharmacology Reports · 615 citations
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Alpha A. Fowler, Aamer Syed, Shelley Knowlson et al. · 2014 · Journal of Translational Medicine · 560 citations
Vitamin C in Disease Prevention and Cure: An Overview
Shailja Chambial, Shailendra Dwivedi, Kamla Kant Shukla et al. · 2013 · Indian Journal of Clinical Biochemistry · 535 citations
Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
Martin Doseděl, Eduard Jirkovský, Kateřina Macáková et al. · 2021 · Nutrients · 474 citations
Vitamin C (L-ascorbic acid) has been known as an antioxidant for most people. However, its physiological role is much larger and encompasses very different processes ranging from facilitation of ir...
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Brian D. Lawenda, Kara M. Kelly, Elena J. Ladas et al. · 2008 · JNCI Journal of the National Cancer Institute · 462 citations
Despite nearly two decades of research investigating the use of dietary antioxidant supplementation during conventional chemotherapy and radiation therapy, controversy remains about the efficacy an...
Reading Guide
Foundational Papers
Start with Fowler et al. (2014) for IV safety in sepsis; Mandl et al. (2009) for core pharmacology; Lawenda et al. (2008) for therapy interactions.
Recent Advances
Doseděl et al. (2021) for comprehensive kinetics; Fujii et al. (2020) for septic shock trials; Wu et al. (2020) for COVID applications.
Core Methods
HPLC for ascorbate quantification; compartmental modeling for clearance; phase I dosing escalation (6-24g/day) with PK sampling.
How PapersFlow Helps You Research Pharmacokinetics of Intravenous Ascorbic Acid
Discover & Search
Research Agent uses searchPapers('pharmacokinetics intravenous ascorbic acid sepsis') to find Fowler et al. (2014), then citationGraph reveals 560 citing papers on dosing safety, and findSimilarPapers uncovers Doseděl et al. (2021) for kinetics details.
Analyze & Verify
Analysis Agent applies readPaperContent on Fowler et al. (2014) to extract plasma curves, runPythonAnalysis to plot dose-response with pandas/matplotlib, and verifyResponse via CoVe with GRADE grading confirms high evidence for 6g q6h safety in sepsis.
Synthesize & Write
Synthesis Agent detects gaps in nonlinear modeling from Fujii et al. (2020) and Lawenda et al. (2008); Writing Agent uses latexEditText for dosing equations, latexSyncCitations across 10 papers, and latexCompile for a review manuscript with exportMermaid for pharmacokinetic flowcharts.
Use Cases
"Plot plasma concentration curves from IV vitamin C sepsis trials using Python."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Fowler 2014) → runPythonAnalysis (NumPy/pandas curve fitting) → matplotlib plot of peak levels vs time.
"Write LaTeX section on IV ascorbic acid pharmacokinetics for sepsis review."
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert kinetics equations) → latexSyncCitations (Fowler/Doseděl) → latexCompile → PDF with diagrams.
"Find code for ascorbic acid pharmacokinetic modeling from papers."
Research Agent → searchPapers('ascorbic acid pharmacokinetics model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → cloned PK simulation script.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'intravenous ascorbic acid pharmacokinetics sepsis', structures report with GRADE scores on Fowler (2014) evidence. DeepScan's 7-step chain verifies nonlinear kinetics claims from Doseděl (2021) with CoVe checkpoints. Theorizer generates hypotheses on tissue targeting from Carr (2017) and Mandl (2009).
Frequently Asked Questions
What defines pharmacokinetics of IV ascorbic acid?
It examines plasma peaks >1mM, rapid clearance via kidneys, and 100% bioavailability versus oral limits (Doseděl et al., 2021).
What methods measure IV vitamin C kinetics?
HPLC assays track plasma levels post-infusion; phase I trials use 6g q6h dosing with serial sampling (Fowler et al., 2014).
What are key papers?
Fowler et al. (2014, 560 citations) proves sepsis safety; Doseděl et al. (2021, 474 citations) details kinetics; Mandl et al. (2009, 441 citations) covers pharmacology.
What open problems exist?
Nonlinear modeling at high doses, tissue pharmacokinetics in disease, and optimal sepsis regimens lack consensus (Fujii et al., 2020).
Research Vitamin C and Antioxidants Research with AI
PapersFlow provides specialized AI tools for Nursing researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pharmacokinetics of Intravenous Ascorbic Acid with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Nursing researchers